Protagonist Therapeutics, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on August 7, 2018, by Protagonist Therapeutics, Inc., a Delaware corporation and emerging growth company. The filing reports the financial results for the quarter ended June 30, 2018.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed data. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior period. It only confirms the reporting of second-quarter 2018 results.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information is furnished and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q2 2018 financial figures.
- Verify the company's cash runway and burn rate, as these are not listed in the 8-K text.
- Confirm the status of clinical trials and pipeline milestones referenced in the full press release.
- Check for any subsequent filings that may update the financial condition reported on August 7, 2018.